4-methyl-1-[[4-[(1Z,3Z)-penta-1,3-dienyl]-2-prop-1-en-2-yl-3H-pyrrol-5-yl]methyl]piperidine
C19H28N2 — CID 143722184
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-methyl-1-[[4-[(1Z,3Z)-penta-1,3-dienyl]-2-prop-1-en-2-yl-3H-pyrrol-5-yl]methyl]piperidine
4-methyl-1-[[4-[(1Z,3Z)-penta-1,3-dienyl]-2-prop-1-en-2-yl-3H-pyrrol-5-yl]methyl]piperidine (PubChem CID 143722184) has the molecular formula C19H28N2 and a molecular weight of 284.45 g/mol. Its IUPAC name is 4-methyl-1-[[4-[(1Z,3Z)-penta-1,3-dienyl]-2-prop-1-en-2-yl-3H-pyrrol-5-yl]methyl]piperidine.
Molecular Properties
| Compound Name | 4-methyl-1-[[4-[(1Z,3Z)-penta-1,3-dienyl]-2-prop-1-en-2-yl-3H-pyrrol-5-yl]methyl]piperidine |
|---|---|
| PubChem CID | 143722184 |
| Molecular Formula | C19H28N2 |
| Molecular Weight | 284.45 g/mol |
| Exact Mass | 284.23 |
| IUPAC Name | 4-methyl-1-[[4-[(1Z,3Z)-penta-1,3-dienyl]-2-prop-1-en-2-yl-3H-pyrrol-5-yl]methyl]piperidine |
| SMILES | C=C(C)C1=NC(CN2CCC(C)CC2)=C(/C=C\C=C/C)C1 |
| InChI | InChI=1S/C19H28N2/c1-5-6-7-8-17-13-18(15(2)3)20-19(17)14-21-11-9-16(4)10-12-21/h5-8,16H,2,9-14H2,1,3-4H3/b6-5-,8-7- |
| InChIKey | HQVQCROGWDDIDH-ISTTXYCBSA-N |
| XLogP | 4.53 |
| TPSA | 15.60 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 284.45 |
| LogP ≤ 5 | 4.53 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'polyene', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 143722184 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.